DOI: 10.2337/diabetes.55.01.06.db05-0598 © 2006 by the American Diabetes Association
The Diabetes Type 1 Locus Idd6 Modulates Activity of CD4+CD25+ Regulatory T-Cells
1 Unité de Génétique Moléculaire Murine, Centre National de Recherche (CNRS) Unité de Recherche Associée (URA) 2578, Institut Pasteur, Paris, France Address correspondence and reprint requests to Dr. U.C. Rogner, Génétique Moléculaire Murine, CNRS URA 2578, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France. E-mail: urogner{at}pasteur.fr
Abbreviations:
FACS, fluorescence-activated cell sorter; IAA, insulin autoantibody; QTL, quantitative trait locus
The genetic locus Idd6 confers susceptibility to the spontaneous development of type 1 diabetes in the NOD mouse. Our studies on disease resistance of the congenic mouse strain NOD.C3H 6.VIII showed that Idd6 influences T-cell activities in the peripheral immune system and suggest that a major mechanism by which the Idd6 locus modifies diabetes development is via modulation of regulatory T-cell activities. Our transfer experiments using total splenocytes and purified T-cells demonstrated that the locus specifically controls the efficiency of disease protection mediated by the regulatory CD4+CD25+ T-cell subset. Our data also implicate the Idd6 locus in controlling the balance between infiltrating lymphocytes and antigen-presenting cells within the pancreatic islet.
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||